Peptides & GLP-1 · Guide

Peptide Safety and Sourcing: A Buyer's Checklist

The compound is rarely the biggest risk. Where it came from usually is.

By Julien Malet, Editor · Updated 2026-09-04

Most peptide conversations focus on what a compound does. The more consequential question is almost always what is actually in the vial, and that is a supply-chain question rather than a pharmacology one.

The four tiers of sourcing

Understanding which tier you are buying from tells you more about your risk than the compound name does.

1. FDA-approved, pharmacy-dispensed. Brand-name semaglutide, tirzepatide and similar. Verified identity, purity, sterility and dose. A clinician monitors you. The most expensive and the only tier with real guarantees.

2. Compounded by a licensed pharmacy. Made to order by a 503A or 503B pharmacy. Legitimate compounding serves real clinical needs, but compounded drugs are not FDA-approved, and the agency has warned about dosing errors from patient self-measurement and about salt forms of semaglutide that are not the same ingredient as the approved drug. When a shortage is declared resolved, the legal basis for mass compounding of that drug narrows sharply — so ask what changed.

3. "Research grade" / "not for human consumption." Sold online with a disclaimer whose function is to move legal liability to you. No verified identity, purity, sterility or dose. No regulator involved.

4. Unlabelled resale. Telegram, forums, gym contacts. No provenance at all.

The drop in assurance between tiers 2 and 3 is the largest one, and it is where most of this market sits.

What goes wrong

Independent testing of grey-market peptides has repeatedly found underdosing, mislabelling, contamination with bacterial endotoxin, and products that were not the advertised compound. The specific failure modes worth knowing:

• Dosing errors. Reconstituting a lyophilised powder and drawing a dose in units from an insulin syringe is a genuine arithmetic problem, and the FDA has documented serious overdoses from patients getting it wrong — some by factors of ten.
• Sterility. Anything injected bypasses every barrier your body has. Non-sterile product is a direct route to infection.
• Identity. A white powder is a white powder. You cannot verify it by looking.
• Storage. Peptides degrade with heat and time. Shipping conditions are invisible to you.

The checklist

If you are buying anything in this category, work through these:

1. Which tier is this? If the answer is 3 or 4, everything below is a partial mitigation, not a fix.
2. Is there a certificate of analysis, and is it for this batch? A generic COA, or one with no batch number matching your vial, is decoration.
3. Was the COA produced by an independent lab? A seller's own assay is a marketing document.
4. Does the product say "not for human consumption"? Then the seller has already told you not to do the thing you are planning. That sentence is load-bearing.
5. Is the compound approved for anything? BPC-157 sits in the FDA's Category 2 for compounding and is not a lawful supplement. NMN's status as a supplement is unresolved. That is not paperwork trivia — it is why no quality system covers it.
6. Are you tested in sport? Many of these are banned at all times by WADA.
7. Who is monitoring you? For prescription-tier compounds, the monitoring is part of the treatment. Self-administering without it removes the part that catches problems early.

Interactions worth naming

Peptides are not inert, and the combinations that matter most:

• GLP-1s plus insulin or sulfonylureas raises hypoglycaemia risk. Doses usually need adjusting by a prescriber.
• GLP-1s slow gastric emptying, which changes the absorption of oral medications and matters for anaesthesia — tell your surgeon and anaesthetist.
• Anything vasoactive plus nitrates or PDE5 inhibitors deserves a clinician's input. Same principle as supplement interactions.

The uncomfortable summary

The regulated tier is expensive because someone is accountable for what is in the vial. Every tier below it is cheaper because nobody is.

That is a trade people make knowingly all the time. Make it knowingly.

Not medical advice. These are prescription and unapproved compounds; a clinician is the right person to talk to.